Related Experiment Videos
Removing the primary tumor after the cancer has spread
The New England Journal of Medicine
|January 5, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contra.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy.
British journal of cancer·2015
Myeloproliferative Neoplasms.
The New England journal of medicine·2026
Treatment Initiation of Definitive Radiotherapy in Patients With Locally Advanced Head and Neck Cancer.
Cancer control : journal of the Moffitt Cancer Center·2026
Octreotide as Adjunctive Therapy for Catecholamine-Secreting Pheochromocytoma and Paraganglioma.
The Journal of clinical endocrinology and metabolism·2026
Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.
Journal of comparative effectiveness research·2026